Annovis Bio (ANVS) Stock: Buy, Sell, or Hold?
$0.85
-0.01 (-0.71%)
▼
5d:
+26.66%
30d:
-16.94%
90d:
-54.21%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
51/100
Position
OVERSOLD
30-Day Fair Range
$0.89 – $1.15
Position: OVERSOLD
Forward P/E & Valuation
-1.0x
Next 12M consensus est.
Wall Street Target
$10.50
+1139.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.62 / $1.40
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ANVS shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ANVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ANVS is currently trading at $0.85, which is considered oversold relative to its 30-day fair value range of $0.89 to $1.15.
Technical Outlook: Technically, ANVS is in a strong downtrend. Immediate support is located at $0.62, while resistance sits at $1.40.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $10.50 (+1139.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ANVS is in a strong downtrend. Immediate support is located at $0.62, while resistance sits at $1.40.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $10.50 (+1139.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.89 -
$1.15
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$0.89 -
$1.15
Current vs Trading Range
OVERSOLD
Support Level
$0.62
Resistance Level
$1.40
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1139.4% below Wall St target ($10.50)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.99
Wall Street Target
$10.50
(+1139.4%)
Share ANVS Analysis
Share this live ANVS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ANVS)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message expresses gratitude for Annovis' Alzheimer's and Parkinson's treatment efforts.
Key Retail Themes:
company's role in Alzheimer's and Parkinson's treatment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:54 PM ET
Data refreshes hourly during market hours. Next update: 8:54 PM
Data refreshes hourly during market hours. Next update: 8:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ANVS Research Pages
